
|

| |
Track this Pro and follow
their portfolio moves with tickerspy™ alerts |
 |
|
 | Abingworth |
| |
Performance |
|
|
|
Similar Pro Portfolios |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
-1.6%
-1.1%
+4.4%
+11.3%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.9%
-0.9%
-1.9%
-20.7%
|
Data since: Jan-1-2011 Current Portfolio: Q1 2013
|
|
|
|
|
|
|
|
|
Share this Pro on Facebook
Share this Pro on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ALNY |
$27.84 |
-0.19 |
-0.68% |
456,401 |
106% |
$1.7B |
- |
185% |
-3% |
+18.3% |
$12.5M | 514.1K shares - decrease of 600.0K shares
1 Alert (0 News) - View
|
|
|
| ALXA |
$4.67 |
-0.01 |
-0.21% |
408,779 |
63% |
$73.9M |
- |
83% |
-30% |
+6.1% |
$1.3M | 286.9K shares - decrease of 1 shares
1 Alert (0 News) - View
|
|
|
| AMRN |
$6.89 |
-0.09 |
-1.29% |
3,728,698 |
97% |
$1.0B |
- |
9% |
-57% |
-6.4% |
$59.9M | 8.1M shares - No Change
1 Alert (1 News) - View
|
|
|
| ANTH |
$0.60 |
0.00 |
0.00% |
665,168 |
103% |
$89.3M |
- |
22% |
-81% |
-8.4% |
$2.3M | 3.5M shares - No Change
No Alerts/News
|
|
|
| ASTX |
$5.20 |
-0.43 |
-7.64% |
1,297,220 |
82% |
$526.8M |
- |
225% |
-25% |
+13.8% |
$11.4M | 2.6M shares - decrease of 1.9M shares
1 Alert (0 News) - View
|
|
|
| CLVS |
$33.29 |
-1.90 |
-5.40% |
237,355 |
126% |
$922.6M |
- |
197% |
-17% |
+21.7% |
$26.9M | 938.7K shares - decrease of 364.9K shares
No Alerts/News
|
|
|
| CRTX |
$8.34 |
-0.20 |
-2.34% |
78,083 |
89% |
$225.6M |
- |
169% |
-9% |
+17.1% |
$599.1K | 84.7K shares - No Change
No Alerts/News
|
|
|
| EXEL |
$4.58 |
-0.03 |
-0.65% |
1,293,199 |
79% |
$847.2M |
- |
9% |
-34% |
+0.4% |
$1.9M | 415.0K shares - No Change
No Alerts/News
|
|
|
| HPTX |
$20.37 |
-0.43 |
-2.07% |
91,842 |
109% |
$416.2M |
- |
105% |
-23% |
-18.5% |
$1.6M | 62.5K shares - New Holding
No Alerts/News
|
|
|
| INCY |
$22.32 |
+0.06 |
+0.27% |
1,235,415 |
118% |
$3.0B |
- |
45% |
-15% |
-3.0% |
$6.8M | 290.0K shares - decrease of 290.5K shares
No Alerts/News
|
|
|
| ISIS |
$20.39 |
-0.42 |
-2.02% |
1,415,123 |
79% |
$2.1B |
- |
170% |
-11% |
+19.8% |
$4.5M | 267.6K shares - No Change
No Alerts/News
|
|
|
| OGXI |
$10.17 |
-0.28 |
-2.68% |
74,809 |
94% |
$153.3M |
- |
11% |
-32% |
-5.8% |
$6.8M | 603.7K shares - No Change
No Alerts/News
|
|
|
| SUPN |
$6.60 |
+0.30 |
+4.76% |
3,643,030 |
557% |
$194.6M |
- |
53% |
-60% |
+23.6% |
$20.2M | 3.6M shares - No Change
No Alerts/News
|
|
|
| ZGNX |
$1.51 |
-0.01 |
-0.66% |
414,635 |
63% |
$153.2M |
- |
36% |
-54% |
-15.2% |
$4.2M | 2.3M shares - No Change
No Alerts/News
|
|
|
| ZLCS |
$0.60 |
-0.00 |
-0.48% |
409,943 |
58% |
$76.3M |
- |
39% |
-63% |
-9.5% |
$576.3K | 864.0K shares - No Change
No Alerts/News
|
|
|
|
|
Discuss Abingworth's portfolio
|
|
|
|
| |

|
| |
|
| |

|
| |
Teva Bets on Reformulating Old Drugs as Investors Say 'Show Me' BMY FRX LLY JNJ BIIB ALXA
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 21, 07:01AM from (www.bloomberg.com) Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts’ highest-rated stock among the world’s
Flag
Post a comment
Supernus to Present at Two Investor Conferences SUPN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 20, 04:43PM from (globenewswire.com) ROCKVILLE, Md., May 20, 2013 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical
Flag
Post a comment
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference ASTX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 06:13AM from (globenewswire.com) DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated
Flag
Post a comment
Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results SUPN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 13, 04:13PM from (globenewswire.com) ROCKVILLE, Md., May 13, 2013 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical
Flag
Post a comment
Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S. TEVA ALXA
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 08, 08:30AM from (www.businesswire.com) Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA), and Alexza Pharmaceuticals,
Flag
Post a comment
REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call CRTX
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 08, 08:00AM from (www2.marketwire.com) Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday,
Flag
Post a comment
Exelixis Announces First Quarter 2013 Financial Results EXEL
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:15PM from (www.businesswire.com) Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the quarter ended March 31, 2013. Q1 2013 Highlights and
Flag
Post a comment
Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More AIG TIF TJX INCY COH JCP TMUS ANR
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 07, 08:35AM from (247wallst.com) Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not
Flag
Post a comment
Clovis Oncology Announces First Quarter 2013 Operating Results CLVS
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 07:00AM from (www.businesswire.com) Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for its first quarter ended March 31, 2013, and provided
Flag
Post a comment
|
|